KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) EBT Margin (2016 - 2025)

Historic EBT Margin for Biolife Solutions (BLFS) over the last 16 years, with Q3 2025 value amounting to 2.5%.

  • Biolife Solutions' EBT Margin rose 50800.0% to 2.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.55%, marking a year-over-year decrease of 214300.0%. This contributed to the annual value of 13.89% for FY2024, which is 104600.0% up from last year.
  • Per Biolife Solutions' latest filing, its EBT Margin stood at 2.5% for Q3 2025, which was up 50800.0% from 61.81% recorded in Q2 2025.
  • In the past 5 years, Biolife Solutions' EBT Margin registered a high of 2.5% during Q3 2025, and its lowest value of 219.83% during Q4 2022.
  • Moreover, its 5-year median value for EBT Margin was 22.14% (2022), whereas its average is 50.96%.
  • Per our database at Business Quant, Biolife Solutions' EBT Margin crashed by -1900600bps in 2021 and then soared by 1757700bps in 2024.
  • Quarter analysis of 5 years shows Biolife Solutions' EBT Margin stood at 49.12% in 2021, then tumbled by -348bps to 219.83% in 2022, then increased by 16bps to 185.16% in 2023, then skyrocketed by 95bps to 9.39% in 2024, then skyrocketed by 127bps to 2.5% in 2025.
  • Its EBT Margin was 2.5% in Q3 2025, compared to 61.81% in Q2 2025 and 1.81% in Q1 2025.